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Dear	Editors		Thank	 you	 for	 reviewers’	 comments	 on	 our	 revised	 manuscript	 entitled	 ‘Intracellular	 neutralisation	 of	
rotavirus	by	VP6-specific	IgG’	(PPathogens-2020-00106R1).			We	are	pleased	that	reviewer	1	was	largely	satisfied	with	our	revision,	and	we	have	the	following	responses	to	their	latest	comments;		
Reviewer	#1:	This	is	a	revision	of	the	original	manuscript	by	Caddy	SL	et	al.	Specifically,	the	authors	made	extensive	
edits	to	the	text	and	added	new	supplementary	figures	1-4	to	address	the	potential	concerns.	Most	of	the	points	raised	
were	satisfactorily	addressed.	However,	this	reviewer	finds	the	response	to	Question	1	insufficient.	[In	Fig.	1A,	is	there	
a	reason	why	“fluorescent	focus	forming	reduction	assay”	was	used	as	opposed	to	traditional	plaque	forming	unit	
assays?]	Plaque	assays	unable	to	“provide	more	rapid	results	(16	hours	v	3-4	days)”	and	“a	highthroughput	method	
using	the	high	content	Nikon	Eclipse	Ti	microscope.”	seem	irrelevant	here.		
	Thank	you	for	your	comment,	and	apologies	if	we	have	misunderstood	your	original	question	regarding	the	use	of	plaque	assays.	We	chose	to	use	a	focus	forming	assay	(FFA)-based	approach	to	study	virus	replication	as	the	FFA	is	a	standard	test	that	is	widely	used	in	virology	and	shown	to	provide	comparable	results	to	plaque	assays	(Yang	et	al,	Clin	Diagn	Lab	Immunol.	1998	Nov;5(6):780-3).	Our	comment	on	the	more	rapid	timescale	provided	by	the	FFA	was	because,	all	things	being	equal,	a	shorter	timescale	is	a	practical	advantage.		
	
Other	alternative	approaches	such	as	focus	forming	unit	assays	and	quantitative	PCR	are	also	readily	available	to	
confirm	the	authors’	findings.		
	There	may	be	some	misunderstanding	here	but	the	assay	we	used	is	a	focus	forming	unit	assay,	which	is	itself	simply	a	variation	of	a	plaque	assay.	Our	assay	uses	immunostaining	with	fluorescently	labelled	antibodies	specific	for	viral	antigen	instead	of	relying	on	cell	lysis.	We	used	the	phrase	‘reduction	assay’	to	reflect	the	fact	that	we	are	using	antibody-mediated	neutralisation	to	reduce	the	number	of	foci	forming.	We	agree	 that	qPCR	 is	a	 readily	available	 technique	and	a	useful	approach	 to	probe	viral	biology.	However,	 it	measures	 RNA	 levels	 and	 not	 infectious	 viral	 progeny.	 The	 FFA	 we	 used	 is	 a	 more	 direct	 measure	 of	 virus	replication.		
	
The	fact	that	“sheep	polyclonal	anti-rotavirus	antibody	that	targets	all	viral	proteins	as	our	detection	reagent”	does	
not	give	support	to	the	validity	of	the	assay	used	in	Fig.	1.		The	read	out	for	our	intracellular	neutralisation	assay	is	simply	infected	cells,	which	is	detected	by	the	use	of	a	secondary	antibody	that	can	detect	a	wide	range	of	viral	proteins.	If	electroporated	antibodies	were	competing	with	the	detection	antibodies,	then	we	would	expect	to	see	a	comparable	decrease	in	infection	with	both	VP6	and	VP4-specific	antibodies,	but	we	have	demonstrated	that	only	electroporation	of	VP6-specific	antibodies	results	in	a	decrease	in	infected	cells	(Fig	1D).			
Two	minor	points:	1)	“dependant”	should	be	“dependent”	in	marked	document,	lines	425	and	905;		This	has	been	corrected	as	advised.	
	
Statistics	should	be	applied	to	Figs.	3A,	3C,	4A-C,	and	S4A-B.	These	have	been	added	to	each	figure,	and/or	discussed	in	the	results	section	as	advised.	
	Thank	you	for	your	consideration	of	this	revision,	and	we	hope	that	you	will	now	find	our	revised	manuscript	suitable	for	publication.		Kind	regards,			Sarah	Caddy	and	Leo	James		
